Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Co-Chairs Centrexion Therapeutics & Metys Pharmaceuticals invite to SMi’s 19th Annual Pain Therapeutics

Read more

Conference Co-Chairs from MedImmune & Ferring Pharmaceuticals invites you to attend Pre-filled Syringes West Coast 2019

Read more

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Read more

Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital

Read more

Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease Portfolio

Read more

Novartis to pursue transformational therapy to reduce risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a)

Read more

Brilinta’s Phase III THEMIS trial met primary endpoint in patients with established coronary artery disease and type-2 diabetes

Read more

AbbVie and Voyager Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies

Read more

Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune

Read more

Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine

Read more

Posts pagination

Previous Page 1 of 957 … Page 675 of 957 … Page 957 of 957 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version